RecruitingPhase 3NCT05850689

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Studying Mal de débarquement

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Intra-Cellular Therapies, Inc.
Intervention
Lumateperone(drug)
Enrollment
470 target
Eligibility
18-65 years · All sexes
Timeline
20232026

Study locations (30)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05850689 on ClinicalTrials.gov

Other trials for Mal de débarquement

Additional recruiting or active studies for the same condition.

See all trials for Mal de débarquement

← Back to all trials